核苷逆转录酶抑制剂和非核苷逆转录酶抑制剂在大部分国家都有。

NRTIs and NNRTIs are available in most countries.

逆转录酶基因耐药性突变的发生率是38.9%（14/36）。

The mutation rate of resistance to reverse transcriptase was 38.9 %(14/36).

但是她提出，仅仅靠抗逆转录酶病毒疗法(简称art)是无法解决这个问题的。

But she noted that antiretroviral therapy, or ART, alone will not solve the problem.

有各种逆转录酶聚合酶链反应(扩增核糖核酸基因组RT–PCR)检测试验方法，但灵敏度各不相同。

Various reverse transcriptase–polymerase chain reaction (RT–PCR) methods are available but are of variable sensitivity.